Controlled Education Of Patients After Stroke (CEOPS)

December 8, 2025 updated by: University Hospital, Lille
The main objective of the study is to compare the benefit of optimised follow-up by nursing personnel from the vascular neurology department, including therapeutic follow-up and an educational program directed to the patient and a caregiving member of his social circle, with that of a typical follow-up.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

290

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Amiens, France
        • CHU Amiens Picardie
      • Besançon, France, 25000
        • CHU
      • Bordeaux, France, 33076
        • CHU
      • Brest, France
        • CHRU Brest
      • Bron, France
        • Hopital Pierre Wertheimer - HCL
      • Calais, France, 62100
        • CH
      • Capinghem, France
        • Samsah Ghicl Capinghem
      • Compiègne, France
        • Ch Intercommunal Compiègne-Noyon - Compiegne
      • Dijon, France, 21000
        • CHU
      • Grenoble, France
        • Chu de Grenoble Alpes - Grenoble 9
      • Lille, France, 59037
        • CHRU
      • Limoges, France
        • C H U Dupuytren Limoges
      • Maubeuge, France
        • Ch Sambre Avesnois Maubeuge
      • Paris, France, 75674
        • Ch Saint Joseph
      • Poitiers, France
        • Chu La Miletrie - Poitiers
      • Rouen, France, 76031
        • CHU
      • Vandœuvre-lès-Nancy, France
        • Chru Nancy - Hopitaux de Braboi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

56 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients over 60 years of age
  • Patients who have had a first stroke, transient or permanent, ischaemic or haemorrhagic, justifying hospitalisation
  • Patients with high blood pressure already treated or discovered at the time of the stroke and justifying the start of a treatment
  • Patients who have had a stroke with sequelae allowing immediate return home or justifying a stay of less than one month in rehabilitation
  • Patient having a member of his social circle who has agreed to provide follow-up for two years in association with the assigned nursing personnel in case of randomisation into the "optimised follow-up" group.

Exclusion criteria

  • Patients less than 60 years of age
  • Patients with a history of stroke
  • Patients who do not have high blood pressure discovered by a treatment prior to the stroke or by abnormal blood pressure figures during hospitalisation
  • Patients who have had a stroke causing serious sequelae, justifying an extended stay in a rehabilitation department
  • Patient who has no one in his social circle capable of working with the assigned nursing personnel, or patient living in an institution

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: optimised follow-up
optimised follow-up will be done by nursing personnel associated with a caregiving member of his social circle.
Other: optimised follow-up
optimised follow-up will be done by nursing personnel associated with a caregiving member of his social circle.
No Intervention: typical follow-up
no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood pressure
Time Frame: 12 months
blood pressure will be measured by nursing personnel who do not know the group into which the patient has been randomised.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcome of stroke
Time Frame: 6 months 12 months 2 years.
functional handicap (Rankin scale) cognitive state (MoCA scale)
6 months 12 months 2 years.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Lille

Collaborators

Ministry of Health, France

Investigators

  • Principal Investigator: REGIS BORDET, MD phD, University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2014

Primary Completion (Actual)

December 16, 2021

Study Completion (Actual)

December 16, 2021

Study Registration Dates

First Submitted

May 5, 2014

First Submitted That Met QC Criteria

May 6, 2014

First Posted (Estimated)

May 7, 2014

Study Record Updates

Last Update Posted (Estimated)

December 16, 2025

Last Update Submitted That Met QC Criteria

December 8, 2025

Last Verified

February 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2011_34
  • 2012-A00473-40 (Other Identifier: ID-RCB number, ANSM)
  • PHRIP 2012 - N°12-019-0306 (Other Identifier: DGOS)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on optimised follow-up

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe